Literature DB >> 26293863

From Molecules to Patients: The Clinical Applications of Translational Bioinformatics.

K Regan, P R O Payne1.   

Abstract

OBJECTIVE: In order to realize the promise of personalized medicine, Translational Bioinformatics (TBI) research will need to continue to address implementation issues across the clinical spectrum. In this review, we aim to evaluate the expanding field of TBI towards clinical applications, and define common themes and current gaps in order to motivate future research.
METHODS: Here we present the state-of-the-art of clinical implementation of TBI-based tools and resources. Our thematic analyses of a targeted literature search of recent TBI-related articles ranged across topics in genomics, data management, hypothesis generation, molecular epidemiology, diagnostics, therapeutics and personalized medicine.
RESULTS: Open areas of clinically-relevant TBI research identified in this review include developing data standards and best practices, publicly available resources, integrative systemslevel approaches, user-friendly tools for clinical support, cloud computing solutions, emerging technologies and means to address pressing legal, ethical and social issues.
CONCLUSIONS: There is a need for further research bridging the gap from foundational TBI-based theories and methodologies to clinical implementation. We have organized the topic themes presented in this review into four conceptual foci - domain analyses, knowledge engineering, computational architectures and computation methods alongside three stages of knowledge development in order to orient future TBI efforts to accelerate the goals of personalized medicine.

Entities:  

Keywords:  Translational bioinformatics; clinical informatics; clinical research; personalized medicine; translational science

Mesh:

Year:  2015        PMID: 26293863      PMCID: PMC4587059          DOI: 10.15265/IY-2015-005

Source DB:  PubMed          Journal:  Yearb Med Inform        ISSN: 0943-4747


  26 in total

Review 1.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.

Authors:  Andrea D Weston; Leroy Hood
Journal:  J Proteome Res       Date:  2004 Mar-Apr       Impact factor: 4.466

2.  Drug research and translational bioinformatics.

Authors:  L J Lesko
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

3.  Translational bioinformatics: data-driven drug discovery and development.

Authors:  A J Butte; S Ito
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

Review 4.  Challenges and opportunities for oncology biomarker discovery.

Authors:  Avisek Deyati; Erfan Younesi; Martin Hofmann-Apitius; Natalia Novac
Journal:  Drug Discov Today       Date:  2012-12-29       Impact factor: 7.851

Review 5.  Computational drug repositioning: from data to therapeutics.

Authors:  M R Hurle; L Yang; Q Xie; D K Rajpal; P Sanseau; P Agarwal
Journal:  Clin Pharmacol Ther       Date:  2013-01-15       Impact factor: 6.875

Review 6.  Implementing personalized cancer genomics in clinical trials.

Authors:  Richard Simon; Sameek Roychowdhury
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

7.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254

Review 8.  Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.

Authors:  Jiajia Chen; Daqing Zhang; Wenying Yan; Dongrong Yang; Bairong Shen
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

9.  Chapter 9: Analyses using disease ontologies.

Authors:  Nigam H Shah; Tyler Cole; Mark A Musen
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

10.  Chapter 1: Biomedical knowledge integration.

Authors:  Philip R O Payne
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

View more
  1 in total

1.  Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases.

Authors:  Venkata Satagopam; Wei Gu; Serge Eifes; Piotr Gawron; Marek Ostaszewski; Stephan Gebel; Adriano Barbosa-Silva; Rudi Balling; Reinhard Schneider
Journal:  Big Data       Date:  2016-06       Impact factor: 2.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.